Antimicrobial obturator for use with vascular access devices

Information

  • Patent Grant
  • 10589063
  • Patent Number
    10,589,063
  • Date Filed
    Tuesday, September 19, 2017
    7 years ago
  • Date Issued
    Tuesday, March 17, 2020
    4 years ago
Abstract
An obturator can include antimicrobial features which assist in sterilizing or maintaining the sterility of fluid contained within a vascular access device while the device is not being used for infusion or other access to the patient's vasculature. These antimicrobial features include antimicrobial coatings applied to various surfaces of an obturator and antimicrobial components bonded or otherwise secured to an obturator. Various combinations of antimicrobial coatings and/or components can be used on an obturator as necessary to provide a desired amount of antimicrobial agents within a particular enclosed volume of a vascular access device.
Description
BACKGROUND OF THE INVENTION

The present invention relates generally to obturators for peripheral IV catheters or other vascular access devices. In particular, the present invention relates to obturators that are configured to provide antimicrobial protection to vascular access devices when the obturators are inserted within the vascular access devices.


Catheters are commonly used for a variety of infusion therapies. For example, catheters are used for infusing fluids, such as normal saline solution, various medicaments, and total parenteral nutrition into a patient, withdrawing blood from a patient, as well as monitoring various parameters of the patient's vascular system.


Catheter-related bloodstream infections are caused by the colonization of microorganisms in patients with intravascular catheters and I.V. access devices. These infections are an important cause of illness and excess medical costs. More importantly, these infections often result in patient deaths.


Many techniques have been employed to reduce the risk of infection from a catheter or other intravenous device. For example, catheters have been designed that employ an antimicrobial lubricant or an antimicrobial coating on an inner or outer surface of the catheter. Similarly, antimicrobial lubricants or coatings have been applied to the surfaces of other components of a catheter assembly, components attached to the catheter assembly, or other medical devices which may come in direct contact with the patient's vasculature or in contact with a fluid that may enter the patient's vasculature. Further, some devices or components are made of a material that is impregnated with an antimicrobial agent.


Although these techniques have been beneficial, there are various drawbacks that limit their usefulness. For example, it can be difficult and/or expensive to apply an antimicrobial coating or lubricant to the complex internal and external geometries of many devices or components. Also, some devices or components are preferably made of a material that is not suitable for the application of an antimicrobial coating or that cannot be impregnated with an antimicrobial agent. Because of such difficulties, the current techniques for providing antimicrobial protection are oftentimes not used or, if used, are not adequately applied to provide maximum antimicrobial protection.


BRIEF SUMMARY OF THE INVENTION

The present invention extends to obturators for vascular access devices. An obturator configured in accordance with the present invention can include antimicrobial features which assist in sterilizing or maintaining the sterility of fluid contained within a vascular access device while the device is not being used for infusion or other access to the patient's vasculature.


These antimicrobial features include antimicrobial coatings applied to various surfaces of an obturator and antimicrobial components bonded or otherwise secured to an obturator. Various combinations of antimicrobial coatings and/or components can be used on an obturator as necessary to provide a desired amount of antimicrobial agents within a particular enclosed volume of a vascular access device.


In one embodiment, the present invention is implemented as an obturator for a vascular access device. The obturator includes a catheter portion configured to be inserted through a lumen of the vascular access device and into a proximal end of a catheter of the vascular access device while the catheter is placed intravenously within a patient, and a cap portion configured to secure the obturator to the vascular access device. The catheter portion includes an antimicrobial coating configured to release an antimicrobial agent into fluid contained within the vascular access device.


In another embodiment, the present invention is implemented as an obturator for a vascular access device. The obturator includes a catheter portion configured to be inserted through a lumen of the vascular access device and into a proximal end of a catheter of the vascular access device while the catheter is placed intravenously within a patient, a middle portion configured to be positioned within the lumen of the vascular access device while the catheter portion is inserted into the catheter, and a cap portion configured to secure the obturator to the vascular access device. The obturator further includes an antimicrobial ring positioned around the middle portion. The antimicrobial ring is configured to release an antimicrobial agent into fluid contained within the lumen of the vascular access device.


In another embodiment, the present invention is implemented as an obturator for a vascular access device. The obturator includes a catheter portion configured to be inserted through a lumen of the vascular access device and into a proximal end of a catheter of the vascular access device while the catheter is placed intravenously within a patient, and a base portion configured to be inserted into the lumen to seal the lumen. The obturator further includes an antimicrobial component that is configured to release an antimicrobial agent into fluid contained within the lumen of the vascular access device.


This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This Summary is not intended to identify key features or essential features of the claimed subject matter.


Additional features and advantages of the invention will be set forth in the description which follows, and in part will be obvious from the description, or may be learned by the practice of the invention. The features and advantages of the invention may be realized and obtained by means of the instruments and combinations particularly pointed out in the appended claims. These and other features of the present invention will become more fully apparent from the following description and appended claims, or may be learned by the practice of the invention as set forth hereinafter.





BRIEF DESCRIPTION OF THE DRAWINGS

In order to describe the manner in which the above-recited and other advantages and features of the invention can be obtained, a more particular description of the invention briefly described above will be rendered by reference to specific embodiments thereof which are illustrated in the appended drawings. Understanding that these drawings depict only typical embodiments of the invention and are not therefore to be considered to be limiting of its scope, the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:



FIGS. 1A-1C each illustrate an obturator that includes an antimicrobial coating in accordance with one or more embodiments of the invention. FIG. 1A illustrates a perspective front view of the obturator prior to being inserted into a vascular access device. FIG. 1B illustrates a cross-sectional front view of the obturator of FIG. 1A prior to being inserted into a vascular access device. FIG. 1C illustrates the obturator of FIGS. 1A and 1B after the obturator has been inserted into a vascular access device which in this example is a peripheral intravenous catheter.



FIGS. 2A-2D each illustrate an obturator that includes an antimicrobial ring in accordance with one or more embodiments of the invention. FIG. 2A illustrates a perspective front view of the obturator prior to being inserted into a vascular access device. FIG. 2B illustrates a cross-sectional front view of the obturator of FIG. 2A prior to being inserted into a vascular access device. FIG. 2C illustrates the obturator of FIGS. 2A and 2B after the obturator has been inserted into a vascular access device which in this example is a peripheral intravenous catheter. FIG. 2D illustrates a cut-away perspective front view of the obturator of FIGS. 2A-2C when the obturator is positioned within a ported catheter.



FIGS. 3A and 3B provide cross-sectional front views of an obturator having an antimicrobial coating and a vascular access device. FIG. 3B illustrates the obturator after being inserted into the vascular access device as well as how an antimicrobial agent contained within the antimicrobial agent is released into fluid contained within the lumen of the vascular access device.



FIGS. 4A and 4B provide cross-sectional front views of an obturator having an antimicrobial ring and a vascular access device. FIG. 4A illustrates the obturator prior to being inserted into the vascular access device. FIG. 4B illustrates the obturator after being inserted into the vascular access device as well as how an antimicrobial agent contained within the antimicrobial ring is released into fluid contained within the lumen of the vascular access device.





DETAILED DESCRIPTION OF THE INVENTION

The present invention extends to obturators for vascular access devices. An obturator configured in accordance with the present invention can include antimicrobial features which assist in sterilizing or maintaining the sterility of fluid contained within a vascular access device while the device is not being used for infusion or other access to the patient's vasculature.


These antimicrobial features include antimicrobial coatings applied to various surfaces of an obturator and antimicrobial components bonded or otherwise secured to an obturator. Various combinations of antimicrobial coatings and/or components can be used on an obturator as necessary to provide a desired amount of antimicrobial agents within a particular enclosed volume of a vascular access device.


In one embodiment, the present invention is implemented as an obturator for a vascular access device. The obturator includes a catheter portion configured to be inserted through a lumen of the vascular access device and into a proximal end of a catheter of the vascular access device while the catheter is placed intravenously within a patient, and a cap portion configured to secure the obturator to the vascular access device. The catheter portion includes an antimicrobial coating configured to release an antimicrobial agent into fluid contained within the vascular access device.


In another embodiment, the present invention is implemented as an obturator for a vascular access device. The obturator includes a catheter portion configured to be inserted through a lumen of the vascular access device and into a proximal end of a catheter of the vascular access device while the catheter is placed intravenously within a patient, a middle portion configured to be positioned within the lumen of the vascular access device while the catheter portion is inserted into the catheter, and a cap portion configured to secure the obturator to the vascular access device. The obturator further includes an antimicrobial ring positioned around the middle portion. The antimicrobial ring is configured to release an antimicrobial agent into fluid contained within the lumen of the vascular access device.


In another embodiment, the present invention is implemented as an obturator for a vascular access device. The obturator includes a catheter portion configured to be inserted through a lumen of the vascular access device and into a proximal end of a catheter of the vascular access device while the catheter is placed intravenously within a patient, and a base portion configured to be inserted into the lumen to seal the lumen. The obturator further includes an antimicrobial component that is configured to release an antimicrobial agent into fluid contained within the lumen of the vascular access device.


An obturator for a vascular access device is commonly used as a means of sealing the lumen of a catheter of a vascular access device while the catheter is positioned intravenously but is not being used for infusion, medication administration, or other types of vascular access. As an example, an obturator may be inserted within a peripheral intravenous catheter when the peripheral intravenous catheter will not be used to access the patient's vasculature for a substantial amount of time (e.g. 24 hours).



FIGS. 1A-1C illustrate an example embodiment of an obturator configured in accordance with the present invention. FIG. 1A illustrates a perspective view of an obturator 100 that is configured to be inserted within a peripheral intravenous catheter or another vascular access device, FIG. 1B illustrates a cross-sectional view of obturator 100, and FIG. 1C illustrates a cross-sectional view of obturator 100 when inserted into a peripheral intravenous catheter 150.


Obturator 100 includes a catheter portion 101, a middle portion 102, a base portion 103, and a cap portion 104. Catheter portion 101 is sized so that is can be inserted within the catheter of a peripheral intravenous catheter. In many cases, the outer diameter of catheter portion 101 is configured to be substantially the same as the inner diameter of the catheter of a peripheral intravenous catheter in which obturator 100 is to be used so that catheter portion 101 forms a seal preventing the flow of fluids through the catheter. Accordingly, catheter portion 101 can be defined as the portion of the obturator that is configured to be inserted into a catheter of a vascular access device.


Catheter portion 101 can be configured with various lengths. For example, the length of catheter portion 101 can be configured so that the distal end of catheter portion 101 is positioned at or near the distal end of the catheter. Alternatively, the length of catheter portion 101 can be configured so that the distal end of catheter portion 101 extends distally out from the catheter. Similarly, the length of catheter portion 101 can be configured so that the distal end of the catheter portion is positioned proximally to the distal end of the catheter. In short, the specific length of catheter portion 101 is not essential to the invention and any length of catheter portion 101 can be employed as long as catheter portion 101 extends at least partially into the catheter when obturator 100 is inserted into the vascular access device.


Middle portion 102 comprises a length of obturator 100 that is positioned between catheter portion 101 and base portion 103. In FIGS. 1A-1C, middle portion 102 is shown as having a larger diameter than catheter portion 101. However, middle portion 102 could also be configured with a diameter that is the same as or less than the diameter of catheter portion 101. Middle portion 102 is positioned between catheter portion 101 and base portion 103 so that it remains within the lumen of the vascular access device in which obturator 100 is placed. Accordingly, middle portion 102 refers more particularly to a length of the obturator rather than to a separate or distinguishable portion of the obturator. Therefore, even though the figures identify middle portion 102 as a length of the obturator having a different diameter than the other portions, this is not required.


Base portion 103 comprises a portion of obturator 100 having a diameter that is substantially the same as the diameter of the lumen of the vascular access device in which the obturator is used. Therefore, a purpose of base portion 103 is to seal the lumen of a vascular access device. Although the figures illustrate obturators that include base portions configured to seal the lumen of a vascular access device, an obturator in accordance with the present invention does not require a base portion configured in this manner. For example, an obturator can include a base portion that has a diameter that is less than the diameter of the lumen such that the base portion does not seal the lumen.


Cap portion 104 comprises a proximal portion of obturator 100 that is configured to secure the obturator to the vascular access device. In some embodiments such as is shown in the figures, cap portion 104 can be configured to extend overtop the proximal end of the vascular access device. In such embodiments, an inner surface of cap portion 104 can include threads for locking the cap portion 104 to the vascular access device. Alternatively, an inner surface of cap portion 104 can be configured to form a friction fit with the outer surface of the vascular access device. In other embodiments, cap portion 104 can be designed so that no portion extends overtop the exterior of the vascular access device. In essence, a cap portion 104 can be defined as the portion of the obturator that the user grips to insert and remove the obturator from a vascular access device. In many cases, cap portion 104 will also form a cover overtop the proximal opening of the vascular access device, but this is not required by the invention.


Although this description describes an obturator as including distinct catheter, middle, base, and cap portions, the intent of this description is to assist in the understanding of the invention and should not be construed as limiting the claims. In particular, an obturator in accordance with the present invention could be configured only with distinct cap and catheter portions with the cap portion being the portion that a user grips and the catheter portion extending distally from the cap portion.


In accordance with one or more embodiments of the invention, obturator 100 can also include an antimicrobial coating on one or more portions. The location of the antimicrobial coating can be selected so that the antimicrobial coating will be in contact with residual fluid that remains within the vascular access device after use. As this residual fluid contacts the antimicrobial coating, one or more antimicrobial agents contained within the coating can be dispersed (e.g. eluted or dissolved) into the residual fluid thereby sterilizing or maintaining the sterility of the fluid. In this way, the risk of microbial colonization within the vascular access device is reduced.


As depicted in FIGS. 1A-1C, an antimicrobial coating 110 (which is not visible in these figures) can be applied to catheter portion 101. Antimicrobial coating 110 can extend along any length of catheter portion 110. As depicted in these figures, antimicrobial coating extends from a distal tip of catheter portion 101 to middle portion 102. In some embodiments, antimicrobial coating 110 could also extend along middle portion 102 and/or base portion 103. In other embodiments, antimicrobial coating 110 may only be applied on middle portion 102 and/or base portion 103.


As shown in FIG. 1C, obturator 100 can be inserted into a peripheral intravenous catheter 150 (or another vascular access device). Peripheral intravenous catheter 150 comprises a catheter adapter 152 having a lumen 153, and a catheter 151 that extends distally from catheter adapter 152. As shown, obturator 100 can be inserted into peripheral intravenous catheter 150 so that catheter portion 101 extends into catheter 151. Cap portion 104 can be configured to extend overtop the proximal end/opening of catheter adapter 152.


In the example shown in FIG. 1C, base portion 103 is configured with a diameter that is substantially the same as the diameter of lumen 153. Therefore, when obturator 100 is fully inserted into peripheral intravenous catheter 150, base portion 103 forms a seal within lumen 153. Also, with obturator 100 fully inserted, the proximal end of catheter portion 101 is positioned within lumen 153. As such, a portion of catheter portion 101 that includes antimicrobial coating 110 is contained within lumen 153. In this way, any residual fluid within lumen 153 can come in contact with antimicrobial coating 110 which enables the antimicrobial agents contained within antimicrobial coating to be dispensed within the fluid. Similarly, any fluid that remains within catheter 151 will be in contact with antimicrobial coating 110 on the length of catheter portion 101 that is positioned within catheter 151. Therefore, the antimicrobial agents can be dispensed from obturator 100 both within catheter 151 and lumen 153.



FIGS. 2A-2C illustrate another example embodiment of an obturator configured in accordance with the present invention. FIG. 2A illustrates a perspective view of an obturator 200 that is configured to be inserted within a peripheral intravenous catheter or another vascular access device, FIG. 2B illustrates a cross-sectional view of obturator 200, and FIG. 2C illustrates a cross-sectional view of obturator 200 when inserted into a peripheral intravenous catheter 250.


Obturator 200, like obturator 100, includes a catheter portion 201, a middle portion 202, a base portion 203, and a cap portion 204. In some embodiments, obturator 200 may also include antimicrobial coating 110, as described above, on catheter portion 201. However, in describing FIGS. 2A-2C, it will be assumed that obturator 200 does not include antimicrobial coating 110.


In accordance with one or more embodiments of the invention, obturator 200 can also include an antimicrobial ring 210. Antimicrobial ring 210 can comprise a material that contains one or more antimicrobial agents. As will be further described below, the antimicrobial agents can be contained within the material or on the surface (e.g. as a coating) of the material from which the ring is made. The location of antimicrobial ring 210 can be selected so that the antimicrobial ring will be in contact with residual fluid that remains within the vascular access device after use. As this residual fluid contacts the antimicrobial ring, one or more antimicrobial agents contained within the ring can be dispersed (e.g. eluted or dissolved) into the residual fluid thereby sterilizing or maintaining the sterility of the fluid. In this way, the risk of microbial colonization within the vascular access device is reduced.


As shown in FIGS. 2A-2C, antimicrobial ring 210 is positioned around middle portion 202. Therefore, antimicrobial ring 210 will be positioned within lumen 253 when obturator 200 is inserted into peripheral intravenous catheter 250 as is shown in FIG. 2C. Because antimicrobial ring 210 is positioned within lumen 253, any residual fluid contained in lumen 253 can come in contact with antimicrobial ring 210 thereby causing the antimicrobial agents contained in or on antimicrobial ring 210 to be dispersed into the fluid.


As stated above, in some embodiments, antimicrobial ring 210 can be used on an obturator that also includes an antimicrobial coating 110 on its catheter portion. Using both can ensure that adequate amounts of antimicrobial agents are dispensed in both the catheter and lumen of the catheter adapter since antimicrobial ring 210 can account for the increased amount of antimicrobial agents required to effectively treat the larger volume of the lumen.


In addition to a ring, antimicrobial components of other shapes can also be employed. For example, many differently shaped antimicrobial components can be affixed to an obturator at various locations to provide antimicrobial benefits to a vascular access device. Accordingly, an obturator in accordance with the present invention may include one or more antimicrobial components that are affixed or otherwise secured to the obturator.


Various types of antimicrobial coatings can be employed on obturators in accordance with embodiments of the present invention. In some embodiments, an alcohol-based formulation containing one or more antimicrobial agents can be applied to the surface (e.g. catheter portion 101) of the obturator such as by dipping or spraying. Once applied, the alcohol can dissolve from the surface leaving behind a residue containing the antimicrobial agents thereby forming the antimicrobial coating. In such embodiments, the antimicrobial coating thus formed will dissolve into the fluid within the vascular access device. Using a dissolvable antimicrobial coating can be preferred in many applications where an obturator will be used over a relatively shorter duration of time since the rapid dissolving of the coating results in a quick release of the antimicrobial agents into the fluid. Examples of suitable formulations and methods that can be used to apply the formulations on an obturator are disclosed in U.S. patent application Ser. No. 13/438,559, titled Systems and Methods for Applying a Novel Antimicrobial Coating Material to a Medical Device which is incorporated by reference.


In other embodiments, an antimicrobial coating can be formed of a matrix that includes one or more antimicrobial agents. For example, the matrix can be a polymer or other suitable material that is cured (e.g. via UV curing) or otherwise bonded to the surface of the obturator. In such coatings, the antimicrobial agent will be eluted from the matrix coating in a controlled fashion. Examples of suitable matrixes and methods of applying the matrixes that can be employed to form an antimicrobial coating on an obturator are described in U.S. Pat. No. 8,512,294, titled Vascular Access Device Antimicrobial Materials and Solutions; and U.S. patent application Ser. No. 12/397,760, titled Antimicrobial Compositions; Ser. No. 12/476,997, titled Antimicrobial Coating Compositions; Ser. No. 12/490,235, titled Systems and Methods for Applying an Antimicrobial Coating to a Medical Device; and Ser. No. 12/831,880, titled Antimicrobial Coating for Dermally Invasive Devices; each of which is incorporated by reference.


In some embodiments, an antimicrobial component (e.g. a ring) can be formed of any suitable material and can have an antimicrobial coating formed of either an alcohol-based formulation or a base material matrix and antimicrobial agents as described in the previous paragraphs. In other embodiments, the material from which the antimicrobial component is made can comprise the base material matrix and the antimicrobial agents. In other words, an antimicrobial component can be comprised entirely of a base material matrix or can only have a coating comprised of either the base material matrix or the alcohol-based formulation. In either case, an antimicrobial component can be bonded or mechanically connected to an obturator.


In embodiments of the invention, an obturator can be configured with one or more of the three general types of antimicrobial protection described above. In other words, an obturator can include an antimicrobial coating formed using an alcohol-based formulation, an antimicrobial coating formed of a base material matrix, and an antimicrobial component (whether formed entirely of a base material matrix, having only a coating of a base material matrix, or having a coating of an alcohol-based formulation). Various combinations of these types of antimicrobial protection can be employed on an obturator to give the obturator the desired antimicrobial properties when used within a vascular access device.


In many obturator designs, the catheter portion and base portion of the obturator form seals at opposite ends of the vascular access device effectively creating a locked volume of fluid within the vascular access device. Based on a typical volume of fluid that can be expected to exist within a vascular access device, an obturator can be configured with an appropriate antimicrobial coating and/or component to ensure that the typical volume of fluid will be adequately treated.


To provide an appropriate amount of antimicrobial agents, various factors can be considered including the total surface area or amount (e.g. in weight) of the antimicrobial coating on the obturator, the concentration of the antimicrobial agents within the coating or material, the rate at which the coating or material will elute or dispense the antimicrobial agents, and the type of antimicrobial agent. For example, to achieve a typical inhibitory concentration of 20 ppm for Pseudomonas aeruginosa in a locked volume of 0.16 cc of fluid within a catheter adapter over a 24 hour period, 3.2 μg of chlorhexidine would need to be released from the obturator. Additionally, to attain a typical bacteriocidal concentration of 500 ppm for Pseudomonas aeruginosa, a minimum of 80 μg of chlorhexidine would need to be released from the obturator. Accordingly, in an embodiment where the obturator includes an antimicrobial coating formed using an alcohol-based formulation (i.e. a coating from which the agents dissolve) and the obturator is desired to provide protection against Pseudomonas aeruginosa, an antimicrobial coating having a minimum target weight may range from 3.5 to 81 μg (depending on whether an inhibitory or bacteriocidal concentration is desired). On the other hand, in an embodiment where the obturator includes an antimicrobial coating or component comprised of a base material matrix containing antimicrobial agents (i.e. a coating or component that elutes the agents) and it is desired that the obturator provide antimicrobial protection for a 24 hour period, an antimicrobial coating or component having a surface area as small as 2.5 mm2 may be suitable.


The above examples illustrate that the specific weight of a dissolving antimicrobial coating or surface area of an eluting antimicrobial coating/component can be selected based on the targeted microorganism, the desired antimicrobial effect (e.g. inhibitory or bacteriocidal concentration), the desired duration for which the antimicrobial agents will be effective, the release kinetics (e.g. rate of dissolution or elution) of the coating/component, and the type of antimicrobial agent used (e.g. chlorhexidine gluconate and chlorhexidine diacetate).


One benefit of employing an obturator to distribute antimicrobial agents within a vascular access device between uses of the device is that the obturator can be modified to include an antimicrobial coating and/or component without modifying how the obturator is used. The obturator is therefore a simple means for placing antimicrobial agents in the precise location within the device and at the precise time when they are needed. Another benefit is that an obturator can be provided with an antimicrobial coating and/or component that is configured to distribute a precise amount of antimicrobial agent to the internal volume of the device. As described above, the coating and/or component can be customized based on various factors to provide the necessary amount of antimicrobial agents for a given volume and for a desired purpose.



FIGS. 3A and 3B provide an example of how an antimicrobial coating 310 on an obturator can disperse antimicrobial agents into fluid contained within a vascular access device. In these figures, the antimicrobial coating is represented using the white dots shown on the catheter portion of the obturator. FIG. 3B illustrates that when the obturator is placed within the vascular access device, antimicrobial agents are dispersed into the fluid which is represented by the black dots being dispersed throughout the lumen of the device. In this example, it is assumed that the lumen is full of fluid. However, the antimicrobial agent can be dispersed to fluid within the lumen even when the fluid does not fill the lumen.



FIGS. 4A and 4B provide an example of how an antimicrobial ring 410 on an obturator can disperse antimicrobial agents into fluid contained within a vascular access device. As with FIG. 3B, FIG. 4B illustrates that antimicrobial agents (represented as white dots) contained within or on the antimicrobial component are dispersed into fluid (represented as black dots) contained within the lumen of the device.


The present invention may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative and not restrictive. The scope of the invention is, therefore, indicated by the appended claims rather than by the foregoing description. All changes which come within the meaning and range of equivalency of the claims are to be embraced within their scope.

Claims
  • 1. An obturator for a vascular access device, the obturator comprising: a catheter portion configured to be inserted through a lumen of the vascular access device and into a proximal end of a catheter of the vascular access device when the catheter is placed intravenously within a patient, wherein the catheter portion includes a first outer diameter;a middle portion directly coupled to a proximal end of the catheter portion, wherein the middle portion is configured to be disposed entirely within the lumen of the vascular access device and spaced apart from the vascular access device when the catheter portion is inserted into the catheter, wherein the middle portion includes a second outer diameter;a base portion that is inserted into the lumen and seals the lumen when the obturator is secured to the vascular access device, wherein the base portion includes a third outer diameter, wherein the second outer diameter is less than the third outer diameter and greater than the first outer diameter, wherein the base portion is proximal to the middle portion;an antimicrobial ring positioned around the middle portion and configured to release an antimicrobial agent, wherein the antimicrobial ring is configured to be positioned within the lumen while the catheter portion is inserted into the catheter, wherein the antimicrobial agent is contained within a material of the antimicrobial ring or on a surface of the material, wherein an inner diameter of the antimicrobial ring is approximately equal to the second outer diameter, wherein an outer diameter of the antimicrobial ring is less than the third outer diameter; anda cap portion proximal to the base portion and configured to secure the obturator to the vascular access device.
  • 2. The obturator of claim 1, further comprising an antimicrobial component secured to the base portion.
  • 3. The obturator of claim 1, further comprising an antimicrobial component secured to the catheter portion.
  • 4. The obturator of claim 1, wherein a distal end of the base portion proximate the middle portion is tapered.
  • 5. The obturator of claim 1, wherein a distal end of the middle portion proximate the catheter portion is tapered.
  • 6. The obturator of claim 1, wherein the second outer diameter is constant along at least a portion of the middle portion.
  • 7. An obturator for a vascular access device, the obturator comprising: a catheter portion configured to be inserted through a lumen of the vascular access device and into a proximal end of a catheter of the vascular access device when the catheter is placed intravenously within a patient;a middle portion directly coupled to a proximal end of the catheter portion, wherein the middle portion is configured to be disposed entirely within the lumen of the vascular access device when the catheter portion is inserted into the catheter;a base portion that is inserted into the lumen and seals the lumen when the obturator is secured to the vascular access device, wherein the base portion is inserted into the lumen of the vascular access device, wherein a maximum outer diameter of the base portion is greater than a maximum outer diameter of the middle portion, wherein the maximum outer diameter of the middle portion is greater than a maximum outer diameter of the catheter portion;an antimicrobial ring positioned around the middle portion and configured to release an antimicrobial agent, wherein the antimicrobial ring is configured to be positioned within the lumen while the catheter portion is inserted into the catheter, wherein the antimicrobial agent is contained within a material of the antimicrobial ring or on a surface of the material; anda cap portion proximal to the base portion and configured to secure the obturator to the vascular access device.
  • 8. The obturator of claim 7, further comprising an antimicrobial component secured to the base portion, the middle portion, or the catheter portion.
  • 9. The obturator of claim 7, wherein a distal end of the base portion proximate the middle portion is tapered.
  • 10. The obturator of claim 7, wherein a distal end of the middle portion proximate the catheter portion is tapered.
  • 11. The obturator of claim 7, wherein an outer diameter of the middle portion is constant along at least a portion of the middle portion.
  • 12. The obturator of claim 7, wherein an inner diameter of the antimicrobial ring is approximately equal to the maximum outer diameter of the middle portion, wherein an outer diameter of the antimicrobial ring is less than the maximum outer diameter of the base portion.
RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 14/260,071, filed Apr. 23, 2014, titled ANTIMICROBIAL OBTURATOR FOR USE WITH VASCULAR ACCESS DEVICES, which is incorporated herein in its entirety.

US Referenced Citations (398)
Number Name Date Kind
1844023 Terry Feb 1932 A
3223629 Loeffler Dec 1965 A
3598127 Wepsic Aug 1971 A
3695921 Shepherd Oct 1972 A
3867937 Schwartz Feb 1975 A
3986508 Barrington Oct 1976 A
4068660 Beck Jan 1978 A
4170996 Wu Oct 1979 A
4280500 Ono Jul 1981 A
4334551 Pfister Jun 1982 A
4339336 Hammond Jul 1982 A
4387879 Tauschinski Jun 1983 A
4449693 Gereg May 1984 A
4469483 Becker Sep 1984 A
4512766 Vailancourt Apr 1985 A
4584192 Dell Apr 1986 A
4585435 Vaillancourt Apr 1986 A
4592920 Murtfeldt Jun 1986 A
4603152 Laurin Jul 1986 A
4610674 Suzuki Sep 1986 A
4629743 Hong Dec 1986 A
4629746 Michl Dec 1986 A
4642126 Zador Feb 1987 A
4676782 Yamamoto Jun 1987 A
4677143 Laurin Jun 1987 A
4716032 Westfall Dec 1987 A
4723948 Clark Feb 1988 A
4758225 Cox Jul 1988 A
4781703 Walker Nov 1988 A
4798594 Hillstead Jan 1989 A
4805933 Swisher Feb 1989 A
4838873 Landskron Jun 1989 A
4842591 Luther Jun 1989 A
4846812 Walker Jul 1989 A
4874377 Newgard Oct 1989 A
4880414 Whipple Nov 1989 A
4895566 Lee Jan 1990 A
4897427 Barnavon Jan 1990 A
4915934 Tomlinson Apr 1990 A
4917668 Haindl Apr 1990 A
4925668 Khan May 1990 A
4933178 Capelli Jun 1990 A
4935010 Cox Jun 1990 A
4950257 Hibbs Aug 1990 A
4955890 Yamamoto Sep 1990 A
4976697 Walder et al. Dec 1990 A
4985399 Matsuda Jan 1991 A
4990357 Karakelle Feb 1991 A
5019096 Fox, Jr. May 1991 A
5023082 Friedman Jun 1991 A
5030665 Lee Jul 1991 A
5041097 Johnson Aug 1991 A
5053014 Van Heugten Oct 1991 A
5062836 Wendell Nov 1991 A
5064416 Newgard Nov 1991 A
5077352 Elton Dec 1991 A
5078703 Bryant Jan 1992 A
5084023 Lemieux Jan 1992 A
5085645 Purdy Feb 1992 A
5098410 Kerby Mar 1992 A
5108374 Lemieux Apr 1992 A
5127905 Lemieux Jul 1992 A
5129887 Euteneuer et al. Jul 1992 A
5154703 Bonaldo Oct 1992 A
5156596 Balbierz Oct 1992 A
5167647 Wijkamp Dec 1992 A
5217493 Raad Jun 1993 A
5226898 Gross Jul 1993 A
5234410 Graham Aug 1993 A
5242425 White Sep 1993 A
5256145 Atkinson Oct 1993 A
5290246 Yamamoto Mar 1994 A
5295969 Fischell Mar 1994 A
5330435 Vaillancourt Jul 1994 A
5330449 Prichard Jul 1994 A
5350363 Goode Sep 1994 A
5352205 Dales Oct 1994 A
5357636 Dresdner, Jr. Oct 1994 A
5366505 Farber Nov 1994 A
5380301 Prichard Jan 1995 A
5405323 Rogers Apr 1995 A
5405338 Kranys Apr 1995 A
5456675 Wolbring Oct 1995 A
5456948 Mathisen Oct 1995 A
5487728 Vaillancourt Jan 1996 A
5512199 Khan Apr 1996 A
5520666 Choudhury May 1996 A
5536258 Folden Jul 1996 A
5540661 Tomisaka Jul 1996 A
5547662 Khan Aug 1996 A
5549566 Elias Aug 1996 A
5549577 Siegel Aug 1996 A
5575769 Vaillancourt Nov 1996 A
5589120 Khan et al. Dec 1996 A
5613663 Schmidt Mar 1997 A
5616338 Fox, Jr. Apr 1997 A
5620434 Brony Apr 1997 A
5629006 Hoang May 1997 A
5638812 Turner Jun 1997 A
5651772 Arnett Jul 1997 A
5653695 Hopkins Aug 1997 A
5657963 Hinchliffe Aug 1997 A
5658253 Piontek Aug 1997 A
5676656 Brimhall Oct 1997 A
5688747 Khan Nov 1997 A
5697915 Lynn Dec 1997 A
5698229 Ohsumi Dec 1997 A
5712229 Hopkins Jan 1998 A
5716406 Farber Feb 1998 A
5718678 Fleming, III Feb 1998 A
5738144 Rogers Apr 1998 A
5749861 Guala May 1998 A
5763412 Khan Jun 1998 A
5773487 Sokol Jun 1998 A
5806831 Paradis Sep 1998 A
5810768 Lopez Sep 1998 A
5817069 Arnett Oct 1998 A
5827239 Dillon Oct 1998 A
5830196 Hicks Nov 1998 A
5830401 Prichard Nov 1998 A
5833674 Turnbull Nov 1998 A
5843046 Motisi Dec 1998 A
5861440 Gohla Jan 1999 A
5911710 Barry Jun 1999 A
5944712 Frassica Aug 1999 A
5951519 Utterberg Sep 1999 A
5954698 Pike Sep 1999 A
5957898 Jepson Sep 1999 A
5967490 Pike Oct 1999 A
6039302 Cote, Sr. Mar 2000 A
6046143 Khan Apr 2000 A
6051609 Yu Apr 2000 A
6068622 Sater May 2000 A
6074379 Prichard Jun 2000 A
6077244 Botich Jun 2000 A
6102890 Stivland Aug 2000 A
6117108 Woehr Sep 2000 A
6120784 Snyder, Jr. Sep 2000 A
6127320 Van Ooij Oct 2000 A
6156054 Zadno-Azizi Dec 2000 A
6165168 Russo Dec 2000 A
6171287 Lynn Jan 2001 B1
6217566 Ju Apr 2001 B1
6228073 Noone May 2001 B1
6242526 Siddiqui Jun 2001 B1
6245098 Feeser Jun 2001 B1
6248811 Ottersbach Jun 2001 B1
6273404 Holman Aug 2001 B1
6273869 Vaillancourt Aug 2001 B1
6322847 Zhong et al. Nov 2001 B1
6326417 Jia Dec 2001 B1
6332874 Eliasen Dec 2001 B1
6337357 Fukunishi Jan 2002 B1
6344218 Dodd Feb 2002 B1
6353041 Qian Mar 2002 B1
6492445 Siddiqui Apr 2002 B2
6387075 Stivland May 2002 B1
6413539 Shalaby Jul 2002 B1
6426373 Stange Jul 2002 B1
6475434 Darouiche Nov 2002 B1
6485473 Lynn Nov 2002 B1
6488942 Ingemann Dec 2002 B1
6503353 Peterson Jan 2003 B1
6511462 Itou Jan 2003 B1
6544214 Utterberg Apr 2003 B1
6575958 Happ Jun 2003 B1
6575960 Becker Jun 2003 B2
6576633 Young Jun 2003 B1
6579221 Peterson Jun 2003 B1
6579539 Lawson Jun 2003 B2
6595981 Huet Jul 2003 B2
6663614 Carter Dec 2003 B1
6699221 Vaillancourt Mar 2004 B2
6719726 Meng Apr 2004 B2
6719991 Darouiche Apr 2004 B2
6723350 Burrell Apr 2004 B2
6740063 Lynn May 2004 B2
6808161 Hishikawa Oct 2004 B1
6843784 Modak Jan 2005 B2
6846846 Modak Jan 2005 B2
6861060 Luriya Mar 2005 B1
6883778 Newton Apr 2005 B1
6887270 Miller May 2005 B2
6893456 Lumauig May 2005 B2
6896889 Chevalier May 2005 B2
7008404 Nakajima Mar 2006 B2
7074839 Fansler Jul 2006 B2
7098256 Ong Aug 2006 B2
7115183 Larson Oct 2006 B2
7179849 Terry Feb 2007 B2
7198800 Ko Apr 2007 B1
7232428 Inukai Jun 2007 B1
7232540 Gould Jun 2007 B2
7261925 Nesbitt Aug 2007 B2
7268165 Greten Sep 2007 B2
7347839 Hiejima Mar 2008 B2
7374798 Choo May 2008 B2
7396346 Nakajima Jul 2008 B2
7407707 Gould Aug 2008 B2
7462401 Halfyard Dec 2008 B2
7470254 Basta Dec 2008 B2
7494339 Dias Feb 2009 B2
7498367 Qian Mar 2009 B2
7514477 Klare Apr 2009 B2
7608082 Cuevas Oct 2009 B2
7704935 Davis Apr 2010 B1
7736339 Woehr Jun 2010 B2
7816434 Hackbarth Oct 2010 B2
7871649 Modak Jan 2011 B2
7874467 Pardes Jan 2011 B2
7914494 Hiejima Mar 2011 B2
7981475 Takahashi Jul 2011 B2
8034454 Terry Oct 2011 B2
8034455 Wang Oct 2011 B2
8067402 Whiteford Nov 2011 B2
8133423 Tang Mar 2012 B2
8227050 O'Neil Jul 2012 B1
8231602 Anderson Jul 2012 B2
8263102 Labrecque Sep 2012 B2
8268381 Whiteford Sep 2012 B2
8343523 Toreki Jan 2013 B2
8343525 Davis Jan 2013 B2
8353876 Suwito Jan 2013 B2
8357119 Stout Jan 2013 B2
8388583 Stout Mar 2013 B2
8414547 Difiore Apr 2013 B2
8512294 Harding Aug 2013 B2
8574171 Nesbitt Nov 2013 B2
8622995 Ziebol Jan 2014 B2
8622996 Ziebol Jan 2014 B2
8691887 Ou-Yang Apr 2014 B2
8728030 Woehr May 2014 B2
8840927 Ditizio Sep 2014 B2
9078441 Raad Jul 2015 B2
9138252 Bierman Sep 2015 B2
20010010016 Modak Jul 2001 A1
20010016589 Modak Aug 2001 A1
20010018095 Shlenker Aug 2001 A1
20010032006 Griffin Oct 2001 A1
20010049519 Holman Dec 2001 A1
20010053895 Vaillancourt Dec 2001 A1
20010056133 Montgomery Dec 2001 A1
20020009436 Doyle Jan 2002 A1
20020022660 Jampani Feb 2002 A1
20020028751 Lokkesmoe Mar 2002 A1
20020037260 Budny Mar 2002 A1
20020040092 Siddiqui Apr 2002 A1
20020064858 Yacoby-Zeevi May 2002 A1
20020091424 Biel Jul 2002 A1
20020119111 Kilgour Aug 2002 A1
20020133124 Leinsing Sep 2002 A1
20020144705 Brattesani Oct 2002 A1
20030023208 Osypka Jan 2003 A1
20030060804 Vaillancourt Mar 2003 A1
20030068667 Olson Apr 2003 A1
20030072781 Pelerin Apr 2003 A1
20030105143 Ammendola Jun 2003 A1
20030119932 Al-Akhdar Jun 2003 A1
20030134783 Harshey Jul 2003 A1
20030144362 Utterberg Jul 2003 A1
20030147932 Nun Aug 2003 A1
20030162839 Symington Aug 2003 A1
20030170308 Cleary Sep 2003 A1
20030176848 Gibson Sep 2003 A1
20030206875 Budny Nov 2003 A1
20030215433 Kokai-Kun Nov 2003 A1
20030224032 Read Dec 2003 A1
20040013574 Conway Jan 2004 A1
20040013703 Ralph Jan 2004 A1
20040014864 Milic Jan 2004 A1
20040039349 Modak Feb 2004 A1
20040058829 Hei Mar 2004 A1
20040062592 Shekalim Apr 2004 A1
20040109852 Xu Jun 2004 A1
20040115477 Nesbitt Jun 2004 A1
20040132164 Doyle Jul 2004 A1
20040180829 Bassler Sep 2004 A1
20040185296 Mazzanti Sep 2004 A1
20040230162 Tan Nov 2004 A1
20040234475 Lannibois-Drean Nov 2004 A1
20050008671 Van Antwerp Jan 2005 A1
20050048005 Stockel Mar 2005 A1
20050048124 Sarangapani Mar 2005 A1
20050059731 Albrecht Mar 2005 A1
20050080158 Ong Apr 2005 A1
20050100580 Osborne May 2005 A1
20050118239 Sabesan Jun 2005 A1
20050124970 Kunin Jun 2005 A1
20050131356 Ash Jun 2005 A1
20050143286 Singh Jun 2005 A1
20050147525 Bousquet Jul 2005 A1
20050148928 Molina Jul 2005 A1
20050158253 Budny Jul 2005 A1
20050176905 Moon Aug 2005 A1
20050209581 Butts Sep 2005 A1
20050209583 Powers Sep 2005 A1
20050233950 Madhyastha Oct 2005 A1
20050265931 Qian Dec 2005 A1
20060024372 Utterberg Feb 2006 A1
20060051385 Scholz Mar 2006 A1
20060064159 Porter Mar 2006 A1
20060163515 Ruschke Jul 2006 A1
20060165751 Chudzik Jul 2006 A1
20060165903 Mazzanti Jul 2006 A1
20060177477 Ash Aug 2006 A1
20060239954 Sancho Oct 2006 A1
20060258780 Chaussade Nov 2006 A1
20060259012 Propp Nov 2006 A1
20060281663 Asmus Dec 2006 A1
20070000407 Leong Jan 2007 A1
20070083157 Belley Apr 2007 A1
20070083162 O'Reagan Apr 2007 A1
20070093762 Utterberg et al. Apr 2007 A1
20070112112 Kerschner May 2007 A1
20070112146 Falk May 2007 A1
20070129690 Rosenblatt Jun 2007 A1
20070141524 Brennan Jun 2007 A1
20070160547 Duffy Jul 2007 A1
20070166344 Qu Jul 2007 A1
20070202177 Hoang Aug 2007 A1
20070203574 McGrath Aug 2007 A1
20070225179 Schutz Sep 2007 A1
20070233007 Adams Oct 2007 A1
20070275101 Lu Nov 2007 A1
20070281198 Lousenberg Dec 2007 A1
20080026026 Lu Jan 2008 A1
20080027410 Harding Jan 2008 A1
20080033371 Updegraff et al. Feb 2008 A1
20080039796 Nakajima Feb 2008 A1
20080051737 Paul Feb 2008 A1
20080075761 Modak Mar 2008 A1
20080103487 Miyasaka May 2008 A1
20080108944 Woehr May 2008 A1
20080119789 Kaemmerer May 2008 A1
20080161763 Harding Jul 2008 A1
20080182921 Suh Jul 2008 A1
20080194707 Potter Aug 2008 A1
20080319387 Amisar et al. Dec 2008 A1
20090012220 Yamane Jan 2009 A1
20090036768 Seehusen Feb 2009 A1
20090062766 Howlett Mar 2009 A1
20090101152 Burk Apr 2009 A1
20090110844 Platzer Apr 2009 A1
20090114327 Breunig May 2009 A1
20090117164 Toreki May 2009 A1
20090125118 Gong May 2009 A1
20090157007 McKinnon Jun 2009 A1
20090162530 Nesbitt Jun 2009 A1
20090176907 Subramanian Jul 2009 A1
20090188559 Nesbitt Jul 2009 A1
20090211909 Nesbitt Aug 2009 A1
20090220739 Chougule Sep 2009 A1
20090226541 Scholz Sep 2009 A1
20090281525 Harding Nov 2009 A1
20090299452 Eidenschink Dec 2009 A1
20090317435 Vandesteeg Dec 2009 A1
20090324666 Krongauz Dec 2009 A1
20090324738 Krongauz Dec 2009 A1
20100015200 McClain Jan 2010 A1
20100024648 Breault Feb 2010 A1
20100069854 Okoh Mar 2010 A1
20100106102 Ziebol Apr 2010 A1
20100106103 Ziebol Apr 2010 A1
20100135949 Ou-Yang Jun 2010 A1
20100136209 Ou-Yang Jun 2010 A1
20100137379 Ou-Yang Jun 2010 A1
20100137472 Ou-Yang Jun 2010 A1
20100200017 Kerr Aug 2010 A1
20100204648 Stout Aug 2010 A1
20100204675 Woehr Aug 2010 A1
20100222746 Burkholz Sep 2010 A1
20110009831 Burkholz Jan 2011 A1
20110044850 Solomon et al. Feb 2011 A1
20110065798 Hoang Mar 2011 A1
20110146680 Conway Jun 2011 A1
20110150958 Davis Jun 2011 A1
20110160662 Stout Jun 2011 A1
20110160663 Stout Jun 2011 A1
20110218529 Garcia Sep 2011 A1
20110301553 Goral Dec 2011 A1
20110319825 Goral Dec 2011 A1
20120016318 Hoang et al. Jan 2012 A1
20120078203 Gaube Mar 2012 A1
20120083750 Sansoucy Apr 2012 A1
20120103448 Hopf May 2012 A1
20120111368 Rahimy et al. May 2012 A1
20130090607 McKinnon Apr 2013 A1
20130165868 Isaacson Jun 2013 A1
20130171030 Ferlic et al. Jul 2013 A1
20130196079 Schwalm Aug 2013 A1
20130197485 Gardner et al. Aug 2013 A1
20130204231 Ziebol et al. Aug 2013 A1
20130245568 Kerr Sep 2013 A1
20130274686 Ziebol Oct 2013 A1
20130310764 Burkholz Nov 2013 A1
20130330387 Ou-yang Dec 2013 A1
20160008517 Burkholz Jan 2016 A1
20170095596 Petrak et al. Apr 2017 A1
Foreign Referenced Citations (127)
Number Date Country
1331333 Aug 1994 CA
2133053 Mar 1995 CA
1187598 Jul 1998 CN
1526771 Sep 2004 CN
101353545 Jan 2009 CN
102070983 May 2011 CN
102481391 May 2012 CN
102497894 Jun 2012 CN
3314640 Nov 1983 DE
3913392 Oct 1990 DE
4011867 Oct 1991 DE
202009009602 Dec 2009 DE
0036294 Sep 1981 EP
0070087 Jan 1983 EP
0227230 Jul 1987 EP
0328421 Aug 1989 EP
0338418 Oct 1989 EP
0370997 May 1990 EP
0379271 Jul 1990 EP
0396431 Nov 1990 EP
0414997 Mar 1991 EP
484092 May 1992 EP
0778337 Jun 1997 EP
0992252 Apr 2000 EP
1466645 Oct 2004 EP
1679043 Jul 2006 EP
2868722 May 2015 EP
05277434 Oct 1993 JP
H07-051651 Feb 1995 JP
H0747435 Feb 1995 JP
08-182764 Jul 1996 JP
H08209064 Aug 1996 JP
H08311373 Nov 1996 JP
09151262 Jun 1997 JP
H09157548 Jun 1997 JP
H09176677 Jul 1997 JP
09-324135 Dec 1997 JP
H10-000231 Jan 1998 JP
H10-192415 Jul 1998 JP
H11-507275 Jun 1999 JP
H11322560 Nov 1999 JP
2000178475 Jun 2000 JP
2000264803 Sep 2000 JP
2001072438 Mar 2001 JP
2002510774 Apr 2002 JP
2002282762 Oct 2002 JP
2003342402 Dec 2003 JP
2004043669 Feb 2004 JP
2005028209 Feb 2005 JP
2005512610 May 2005 JP
2005515838 Jun 2005 JP
2005520912 Jul 2005 JP
2007016096 Jan 2007 JP
2008533051 Aug 2008 JP
2009-527356 Jul 2009 JP
2009-528360 Aug 2009 JP
2009-544454 Dec 2009 JP
2010-174075 Aug 2010 JP
2010536836 Dec 2010 JP
2012-510559 May 2012 JP
2012100762 May 2012 JP
2012532681 Dec 2012 JP
2013-505062 Feb 2013 JP
2013533005 Aug 2013 JP
2013540486 Nov 2013 JP
2015-519303 Jul 2015 JP
20020066429 Aug 2002 KR
8200413 Feb 1982 WO
9422522 Oct 1994 WO
9521648 Aug 1995 WO
9616690 Jun 1996 WO
9640359 Dec 1996 WO
9858690 Dec 1998 WO
9858989 Dec 1998 WO
9916498 Apr 1999 WO
9932168 Jul 1999 WO
9934849 Jul 1999 WO
9936490 Jul 1999 WO
9944654 Sep 1999 WO
9943971 Sep 1999 WO
0012171 Mar 2000 WO
0066189 Nov 2000 WO
0074743 Dec 2000 WO
0147592 Jul 2001 WO
0195862 Dec 2001 WO
02051464 Jul 2002 WO
2004071568 Aug 2004 WO
2004108091 Dec 2004 WO
2005037340 Apr 2005 WO
2006012446 Feb 2006 WO
2006056482 Jun 2006 WO
2006074666 Jul 2006 WO
2006088288 Aug 2006 WO
2006099358 Sep 2006 WO
2006099359 Sep 2006 WO
2006100442 Sep 2006 WO
2007052656 May 2007 WO
2007064835 Jun 2007 WO
2007095576 Aug 2007 WO
2007100653 Sep 2007 WO
2007100776 Sep 2007 WO
2008014438 Jan 2008 WO
2008014447 Jan 2008 WO
2008031601 Mar 2008 WO
2008045761 Apr 2008 WO
20080039460 Apr 2008 WO
2008052790 May 2008 WO
2008128896 Oct 2008 WO
2008132045 Nov 2008 WO
2008152849 Dec 2008 WO
2009012336 Jan 2009 WO
2009055949 May 2009 WO
2009070227 Jun 2009 WO
2009114833 Sep 2009 WO
2010034470 Apr 2010 WO
2010093791 Aug 2010 WO
2011005951 Jan 2011 WO
2011034675 Mar 2011 WO
2011048204 Apr 2011 WO
WO-2011118680 Sep 2011 WO
2012036916 Mar 2012 WO
2013009998 Jan 2013 WO
2013134421 Sep 2013 WO
2013151860 Oct 2013 WO
2014031774 Feb 2014 WO
2015133281 Sep 2015 WO
2015137098 Sep 2015 WO
Non-Patent Literature Citations (13)
Entry
Anusavice KJ, Zhang N-Z, Shen C. Controlled Release of Chlorhexidine from UDMA-TEGDMA Resin, Journal of dental research, 2006;85(10); 950-954.
Cabot Corporation, “Using Silicas and Aluminas in Coatins,” www.cabot-corp.com/Silicas-And-Aluminas/Coatings, downloaded from the internet on Apr. 26, 2011.
ComfortCoat Hydrophilic Coating, DSM in Medical, http://www.dsm.com/en_US/medical/public/home/pages/product- coating-comfortcoat.jsp, Updated Jan. 11, 2013, Printed Apr. 22, 2013.
Elson Silva, PhD, “Respecting Hydrology Science in the Patenting System,” pp. 1-7, Jan. 13, 2011.
Enluria, ChloraPrep, http://enluria.com/products/cloraPrep-product.html, pp. 1-3, Oct. 21, 2008.
Gama Healthcare, Clinell Alcoholic 2% Chlorhexidine, http//www.gamahealthcare.com/clinellaca2c.html, pp. 1-3, Nov. 7, 2008.
Gerald McDonnell and A. Denver Russell, Antiseptics and Disinfectants: Activity, Action and Resistance, Clinical Microbiology Reviews, vol. 12, Jan. 1999, p. 147-179.
Lubricent—Lubricious Hydrophillic Coatings for Medical Devices, Harland Medical Systems, http://www. harlandmedical.com/index.php/materials/lubricent.html, pp. 1-2, Printed Apr. 22, 2013.
Sage Products, Inc., Address Multi-Drug Reistant Organism on the Skin with Early Preop Prep, http://www.sageproducts.com/products/ssi-prevention.cfm, 1 page, Oct. 31, 2008.
Ciba Irgacure 500 data sheet from Ciba Specialty Chamicals, online, retrieved on [Dec. 13, 2015]. Retrieved from internet URL <http://www.conquimica.com/wp-content/uploads/2015/06/ft_igracure_500.pdf>.
Sage Products, Inc., Preoperative Skin Preparation and Preoperative Oral Care for the Short-Term Ventilated Patient, http://www.sageproducts.com/products/ssi-vap-prevention.cfm.
Sage Products, Inc., Preoperative Skin Preparation for the Surgical Patient, http://www.sageproducts.com/products/skin-prep.cfm, 1 page, Oct. 31, 2008.
UV & EB Cure, Xiper Innovations, Inc., http://xiperinnovations.com/uv_eb_cure, Printed Apr. 22, 2013.
Related Publications (1)
Number Date Country
20180021543 A1 Jan 2018 US
Continuations (1)
Number Date Country
Parent 14260071 Apr 2014 US
Child 15709221 US